JP2024502740A5 - - Google Patents
Info
- Publication number
- JP2024502740A5 JP2024502740A5 JP2023537184A JP2023537184A JP2024502740A5 JP 2024502740 A5 JP2024502740 A5 JP 2024502740A5 JP 2023537184 A JP2023537184 A JP 2023537184A JP 2023537184 A JP2023537184 A JP 2023537184A JP 2024502740 A5 JP2024502740 A5 JP 2024502740A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- isolated polypeptide
- polypeptide according
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063126736P | 2020-12-17 | 2020-12-17 | |
| US63/126,736 | 2020-12-17 | ||
| PCT/US2021/063920 WO2022133148A1 (en) | 2020-12-17 | 2021-12-16 | Long acting glucagon like polypeptide-1 (glp-1) receptor agonists and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502740A JP2024502740A (ja) | 2024-01-23 |
| JP2024502740A5 true JP2024502740A5 (https=) | 2024-12-23 |
Family
ID=80123475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023537184A Pending JP2024502740A (ja) | 2020-12-17 | 2021-12-16 | 長時間作用型グルカゴン様ポリペプチド－１（ｇｌｐ－１）受容体アゴニスト及び使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US12084485B2 (https=) |
| EP (1) | EP4263587A1 (https=) |
| JP (1) | JP2024502740A (https=) |
| KR (1) | KR20230156689A (https=) |
| CN (1) | CN116917311A (https=) |
| AR (1) | AR124395A1 (https=) |
| AU (1) | AU2021400738A1 (https=) |
| CA (1) | CA3202389A1 (https=) |
| IL (1) | IL303686A (https=) |
| MX (1) | MX2023007224A (https=) |
| TW (1) | TW202237628A (https=) |
| WO (1) | WO2022133148A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3204051A1 (en) | 2021-01-20 | 2022-07-28 | Brian Lian | Compositions and methods for the treatment of metabolic and liver disorders |
| JP7642830B2 (ja) | 2021-09-15 | 2025-03-10 | バイキング・セラピューティクス・インコーポレイテッド | 代謝及び肝臓障害の処置のための組成物及び方法 |
| IL322661A (en) * | 2023-02-10 | 2025-10-01 | Hangzhou Sciwind Biosciences Co Ltd | Polypeptide and its history, composition containing them and their use |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2200626A4 (en) * | 2007-09-07 | 2012-02-15 | Ipsen Pharma Sas | ANALOGUE OF EXENDIN-4 AND EXENDIN-3 |
| RU2547990C2 (ru) * | 2009-09-28 | 2015-04-10 | Интарсия Терапьютикс, Инк. | Быстрое достижение и/или прекращение существенной стабильной доставки лекарственного средства |
| BR112014014898A2 (pt) * | 2011-12-22 | 2020-10-27 | Pfizer Inc. | processo para purificar uma amostra de anticorpo h38c2, ou variante do mesmo, e composição compreendendo o referido h38c2 |
| UA116217C2 (uk) * | 2012-10-09 | 2018-02-26 | Санофі | Пептидна сполука як подвійний агоніст рецепторів glp1-1 та глюкагону |
| KR102574993B1 (ko) * | 2016-05-16 | 2023-09-06 | 인타르시아 세라퓨틱스 인코포레이티드 | 글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법 |
| MX2018014966A (es) * | 2016-06-09 | 2019-08-14 | Medimmune Ltd | Peptidos monolipidados resistentes a proteasas. |
| CN111333714A (zh) * | 2020-03-05 | 2020-06-26 | 成都奥达生物科技有限公司 | 一种长效glp-1化合物 |
-
2021
- 2021-12-16 US US17/553,381 patent/US12084485B2/en active Active
- 2021-12-16 CA CA3202389A patent/CA3202389A1/en active Pending
- 2021-12-16 MX MX2023007224A patent/MX2023007224A/es unknown
- 2021-12-16 KR KR1020237023789A patent/KR20230156689A/ko active Pending
- 2021-12-16 JP JP2023537184A patent/JP2024502740A/ja active Pending
- 2021-12-16 AR ARP210103539A patent/AR124395A1/es unknown
- 2021-12-16 CN CN202180089098.0A patent/CN116917311A/zh active Pending
- 2021-12-16 EP EP21851897.5A patent/EP4263587A1/en not_active Withdrawn
- 2021-12-16 AU AU2021400738A patent/AU2021400738A1/en active Pending
- 2021-12-16 WO PCT/US2021/063920 patent/WO2022133148A1/en not_active Ceased
- 2021-12-16 IL IL303686A patent/IL303686A/en unknown
- 2021-12-17 TW TW110147341A patent/TW202237628A/zh unknown
-
2024
- 2024-07-22 US US18/779,857 patent/US20250034225A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024502740A5 (https=) | ||
| US11510959B2 (en) | Hydrophilic antibody-drug conjugates | |
| US12214059B2 (en) | Cleavable radioligands for targeting cell surface receptors and uses thereof | |
| JP3912798B2 (ja) | 新規アミノ酸誘導体、それらの調製方法及びこれらの化合物を含む医薬組成物 | |
| JP7250814B2 (ja) | 新規ｇｌｐ－１類似体 | |
| BG98489A (bg) | Пептиди,способни да освобождават растежен хормон | |
| TWI618697B (zh) | 化合物、連接子－藥物、及配體－藥物耦合體 | |
| JP2011502159A5 (https=) | ||
| JP2016501204A5 (https=) | ||
| JP2015524796A5 (ja) | 細胞毒性剤と細胞結合受容体との共役体 | |
| JP2023545684A5 (https=) | ||
| JP2023502005A5 (https=) | ||
| JP2023551122A5 (https=) | ||
| JP2022502431A5 (https=) | ||
| IL297368A (en) | Long-acting peptide tyrosine kinase (pyy) analogs and methods of use | |
| EP1159292A2 (en) | Compounds having growth hormone releasing activity | |
| IL299778A (en) | Therapeutic use of glucagon derivative or conjugate thereof for liver disease | |
| JP6113144B2 (ja) | 成長ホルモン放出因子（ｇｒｆ）類似体およびその使用 | |
| KR20250116767A (ko) | 변형 구조가 있는 폴리펩타이드 및 그 용도 | |
| RU2857183C2 (ru) | Производное полиэтиленгликоля, композиция, содержащая такое производное, и способ получения конъюгата биоактивного полипептида с использованием такого производного | |
| TWI882177B (zh) | 聚乙二醇衍生物、包括其之組成物以及使用其之具生物活性胜肽偶聯物之製程 | |
| HK40111230A (zh) | 用於靶向细胞表面受体的可裂解放射性配体及其用途 | |
| JP2004509846A (ja) | 肝炎ｃ型ウイルスコンジュゲート | |
| JP2026031900A (ja) | Ｆｃ－アシル化ポリペプチドコンジュゲート | |
| JP2025508819A5 (https=) |